ATLANTA, April 26, 2011 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Andrew Antoszyk, M.D. will present new 36 months efficacy and safety data of ILUVIEN® for the treatment of diabetic macular edema at the 2011 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida on Tuesday, May 3, 2011. The presentation will be at 9:15 a.m. in Grand H of the Greater Fort Lauderdale/Broward County Convention Center. Dr. Antoszyk is a practicing retina specialist at Charlotte Eye, Ear, Nose and Throat Associates in Charlotte, North Carolina.
